Chymase plays an important role in hepatic inflammation and fibrosis in experimental NASH models via various enzymatic functions, including upregulation of angiotensin II, MMP-9 and TGF-β. Here, CMA1 is linked to metabolic dysfunction-associated steatohepatitis.